Successful Percutaneous Retrieval Of Embolized Transcatheter Left Atrial Appendage Closure Device (Watchman) Using A Modified Vascular Retrieval Forceps
We report the case of a 63-year gentleman who underwent an uneventful LAA closure with watchman device and routine testing next day showed embolization to the abdominal aorta. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 31, 2017 Category: Cardiology Authors: Zaher Fanari, Sachin Goel, Jeffrey A. Goldstein Source Type: research

Here We Go Agasin: Trying to Prevent Contrast Induced Nephropathy
… you'd think that by now I'd know'Cause here we go go go go again(Demi Lovato) (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 31, 2017 Category: Cardiology Authors: Fabio V. Lima, Luis Gruberg Source Type: research

ST Segment Elevation Myocardial Infarction in Patients Hospitalized for Non-Cardiac Conditions
The objective of this study was to analyze treatment times and clinical outcome for in-hospital STEMI patients. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 31, 2017 Category: Cardiology Authors: Justin Tiulim, Kevin Mak, David M. Shavelle Source Type: research

Safety and Efficacy Outcomes of Second-Generation Everolimus-Eluting Stents in Octogenarians Compared to Non-octogenarians
In patients ≥80 years of age, the use of second-generation cobalt-chromium everolimus-eluting stents (CoCr-EES) versus bare-metal stents has been shown to reduce myocardial infarction (MI) and target vessel revascularization (TVR) rates, without an increase in bleeding. However, safety and efficacy of CoCr-EE S in octogenarians compared to younger populations are less certain. We aimed to compare the clinical outcomes between octogenarian and non-octogenarian patients undergoing percutaneous coronary intervention (PCI) with CoCr-EES. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 31, 2017 Category: Cardiology Authors: Hironori Kitabata, Takashi Kubo, Kazuya Mori, Yasunori Yamamoto, Manabu Kashiwagi, Yu Arita, Takashi Tanimoto, Takashi Akasaka Source Type: research

Inadvertent anastomosis of the left internal mammary artery to the great cardiac vein
We present an uncommon and underreported complication of coronary artery bypass graft surgery: erroneous anastomosis of the left internal mammary artery to the great cardiac vein. The iatrogenic aorto-coronary arteriovenous fistula with left-to-right shunting resulted in dilation of the coronary sinus, a supporting secondary finding. Factors predisposing to this inadvertent anastomosis include an intramyocardial segment of the left anterior descending coronary artery, demonstrated in this case, as well as epicardial fat and potentially fibrosis of the underlying myocardium. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 19, 2017 Category: Cardiology Authors: Shahryar G. Saba, John N. Makaryus, Shoshanah Kahn, Rakesh Shah, Perwaiz Meraj Source Type: research

Safety and Predictors of Next Day Discharge After Elective Transfemoral Transcatheter Aortic Valve Replacement
We sought to determine the predictors of next-day discharge (NDD) for selected patients undergoing elective transfemoral transcatheter aortic valve replacement (TF-TAVR). (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 19, 2017 Category: Cardiology Authors: Sulaiman Rathore, Yevgeniy Latyshev, Sheree Emore, Joseph Rowe, Jason Foerst Source Type: research

TAVR and renal function: A love and hate story
The emergence of transcatheter aortic valve replacement (TAVR) as an alternative to the traditional surgical aortic valve replacement (SAVR) was shortly followed by the dilemma of which patient will benefit more from which procedure. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 18, 2017 Category: Cardiology Authors: Saar Minha, Israel M Barbash Source Type: research

In-stent Restenosis Nine Years after Initial Placement of a Drug-Eluting Stent
Drug-eluting stents (DES) represent a significant advance in the field of percutaneous coronary intervention with regard to target vessel revascularization and in reduction of flow limiting in-stent restenosis (ISR). Initially with percutaneous transluminal coronary angioplasty alone, ISR incidence was 32 –55% with only some improvement with bare metal stents (BMS) to 17–41%. DES have dramatically reduced the incidence of ISR to approximately 12% [1,2]. However, flow limiting in-stent restenosis (ISR) continues to be a clinical problem despite technological advances and improved understanding of the underlying mechanis...
Source: Cardiovascular Revascularization Medicine - May 18, 2017 Category: Cardiology Authors: Dennis A Hopkinson, Vikram Raje, Ion S Jovin Source Type: research

Hybrid Metal/Scaffold-Jacket versus Full-Metal Jackets in Left Anterior Descending Coronary Artery Diffuse Disease: Differences in Radiation Exposure and Fluoroscopic/ Procedural Times
Bioabsorbable vascular scaffolds (BVS) are made from a radiolucent material. Their multiple implantation on a single long diffused segment requires a specific technique with imaging magnification, which could cause an increase in dose delivered during percutaneous coronary intervention (PCI) procedure. We aimed to identify differences in radiation dose, fluoroscopy and procedural times in Hybrid DES+multiple BVS (Absorb, Abbott Inc., USA) implantation (hybrid metal/scaffold jacket) versus multiple III generation Drug-eluting stents (DES) (full-metal jacket) in patients with long and diffuse coronary artery disease of the l...
Source: Cardiovascular Revascularization Medicine - May 18, 2017 Category: Cardiology Authors: Gianluca Rigatelli, Marco Zuin, Jacopo Frigato, Fabio Dell'Avvocata, Federico Ronco, Alberto Mazza, Laura Oliva, Dario Adami, Emiliano Bedendo, Panin Stefano Source Type: research

Utility of a 0.035 ″ compatible rapid-exchange balloon (Metacross RX™) as a perfusion balloon in endovascular therapy compared with conventional percutaneous coronary intervention: A mini review
Since endovascular treatment for peripheral artery disease has been rapidly and widely adopted as the preferred strategy, interventionists sometimes experience complications such as vessel perforation and severe dissections. We have a long-time inflation strategy for perfusion balloon catheters, which could be a solution for vessel complications in coronary sections, but not in peripheral sections. We invented a simple device for application as a perfusion balloon in peripheral sections, using a 0.035 ″ wire compatible rapid-exchange balloon Metacross RX™ (TERUMO, Tokyo, Japan) and reviewed this strategy using three ca...
Source: Cardiovascular Revascularization Medicine - May 18, 2017 Category: Cardiology Authors: Keisuke Nakabayashi, Nobuhito Kaneko, Daisuke Sunaga, Akihiro Matsui, Kazuhiko Tanaka, Hiroshi Ando, Minoru Shimizu Source Type: research

Left Ventricular Perforation in a Patient with a Left Ventricular Aneurysm during NOGA ® Catheter Mapping
We present the case of a woman who developed a perforation at the site of an LV aneurysm during NOGA mapping prior to the transendocardial injection of stem cells, as part of a multicenter clinical trial. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 13, 2017 Category: Cardiology Authors: Gaurav K. Sharma, Marie-France Poulin, Gary L. Schaer Source Type: research

Correlation and prognostic role of Neutrophil to Lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: a six-year experience
The neutrophil/lymphocyte ratio (NLR) has been proposed as a prognostic marker in acute myocardial infarction (AMI). The aim of our study is to demonstrates the correlation between SYNTAX score (Sxs) and NLR and its association with 1-year cardiovascular (CV) mortality in patients with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) treated with percutaneous coronary intervention (PCI). (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 12, 2017 Category: Cardiology Authors: Marco Zuin, Gianluca Rigatelli, Claudio Picariello, Fabio dell'Avvocata, Lina Marcantoni, Gianni Pastore, Mauro Carraro, Aravinda Nanjundappa, Giuseppe Faggian, Loris Roncon Tags: Original article Source Type: research

Revascularization Methods in Spontaneous Coronary Artery Dissection: A Focused Review
Spontaneous coronary artery dissection (SCAD) is becoming widely recognized as an important cause of myocardial infarction, particularly in younger women. Tendency towards conservative management has been primarily based on observational data. Intervention is recommended when coronary blood flow is compromised and high risk features such as left main involvement, ongoing ischemia, or hemodynamic or electrical instability are present. Unlike the atherosclerotic process where the superiority of stenting compared with plain old balloon angioplasty has been established in the acute setting, randomized studies for revasculariza...
Source: Cardiovascular Revascularization Medicine - May 12, 2017 Category: Cardiology Authors: Regina Lee, Itsik Ben-Dor Source Type: research

Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS)
Drug-eluting stents (DES) reduce the risk of restenosis after percutaneous coronary intervention. The aim of the study was to evaluate, by intravascular ultrasound (IVUS), the minimum lumen area site in the stented segment and the distribution of intimal hyperplasia in patients presenting with a DES or bare-metal stent (BMS) in-stent restenosis. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 12, 2017 Category: Cardiology Authors: Lisette Okkels Jensen, Saila Vikman, Lisbeth Antonsen, Petteri Kosonen, Matti Niemel ä, Evald Høj Christiansen, Kari Kervinen, Andrejs Erglis, Jan Harnek, Indulis Kumsars, Leif Thuesen, Kari Niemelä Source Type: research

Bioprosthesis Leaflet Thrombosis Following Self-Expanding Valve-in-Valve Transcatheter Aortic Valve Replacement in Patient Taking Factor Xa Inihibitor and Warfarin: A Case Report
An 87year-old female with symptomatic severe aortic stenosis underwent transcatheter valve replacement (TAVR) via the transfemoral approach with a 29mm self-expanding device. Moderate to severe paravalvular regurgitation led to the development of congestive heart failure and hospital readmission one month following TAVR. A second 29mm valve was placed to abolish the paravalvular regurgitation. Routine follow-up computed tomography (CT) imaging demonstrated leaflet thickening and decreased leaflet mobility suggesting valve thrombosis, despite adherence to Factor Xa inhibitor. (Source: Cardiovascular Revascularization Medicine)
Source: Cardiovascular Revascularization Medicine - May 11, 2017 Category: Cardiology Authors: Kyle D Buchanan, M Chadi Alraies, Gaby Weissman, Itsik Ben-Dor, Lowell F Satler, Ron Waksman Source Type: research